These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 9280223

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [To improve the survival rate of patients suffering from locally advanced non-small cell lung cancer with combination of radiotherapy and chemotherapy].
    Zhu GY.
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Feb; 30(2):88-90. PubMed ID: 17445466
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Is preoperative chemotherapy in locally advanced non-small-cell bronchial carcinoma of value?].
    Betticher DC, von Briel C, Gugger M, Cerny T, Ris HB.
    Ther Umsch; 1998 Jul; 55(7):399-401. PubMed ID: 9702102
    [Abstract] [Full Text] [Related]

  • 10. [Management of non-small-cell lung carcinoma (NSCLC) of stage III B].
    Koukourakis M.
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S33-6. PubMed ID: 11924241
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Recent issues in the treatment of advanced non-small-cell lung cancer].
    Negoro S.
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1671-9. PubMed ID: 9757191
    [Abstract] [Full Text] [Related]

  • 14. Trimodal therapy for histologically proven N2/3 non-small cell lung cancer: mid-term results and indicators for survival.
    Steger V, Walles T, Kosan B, Walker T, Kyriss T, Veit S, Dippon J, Friedel G.
    Ann Thorac Surg; 2009 Jun; 87(6):1676-83. PubMed ID: 19463576
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Combined modality therapy for stage III non-small cell lung cancer.
    Stinchcombe TE, Fried D, Morris DE, Socinski MA.
    Oncologist; 2006 Jun; 11(7):809-23. PubMed ID: 16880240
    [Abstract] [Full Text] [Related]

  • 18. Stage IIIA-N2 NSCLC: a review of its treatment approaches and future developments.
    van Meerbeeck JP, Surmont VF.
    Lung Cancer; 2009 Sep; 65(3):257-67. PubMed ID: 19285751
    [Abstract] [Full Text] [Related]

  • 19. The ANITA trial seals the deal for adjuvant therapy in non-small-cell lung cancer.
    Belani CP.
    Clin Lung Cancer; 2005 May; 6(6):331-2. PubMed ID: 15943890
    [No Abstract] [Full Text] [Related]

  • 20. What is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941?
    Van Meerbeeck JP, De Pauw R, Tournoy K.
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):199-206. PubMed ID: 18279061
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.